• New Product Designed to Kill MRSA Registered by the EPA
    BEVERLY, Mass. -- The Environmental Protection Agency (EPA) has recently registered a new product for preventing and eliminating methicillin-resistant Staphylococcus aureus (MRSA).  The EPA has registered Selectrocide chlorine dioxide for use as a disinfectant on hard, ...More
    August 29, 2005 Posted in News
  • Low HDL Level Indicates Poor Prognosis for Sepsis
    DES PLAINES, Ill. -- Critically ill patients with low blood levels of high-density-lipoprotein (HDL) cholesterol, or good cholesterol, on the first day of severe sepsis have a higher mortality rate according to an article in the August issue of Critical Care Medicine."Our ...More
    August 29, 2005 Posted in News
  • AIDS Group Criticizes California Senate Leadership for Stopping Condoms-in-Prisons Bill
    SACRAMENTO, Calif. -- AB 1677 (Paul Koretz, D-West Hollywood), a bill that would have allowed the state of California to grant nonprofit healthcare agencies permission to make sexual barrier protection devices (such as condoms and dental dams) available in California ...More
    August 26, 2005 Posted in News
  • WHO Declares TB an Emergency in Africa
    MAPUTO, Mozambique -- The World Health Organization (WHO) Regional Committee for Africa comprising health ministers from 46 member states has declared tuberculosis an emergency in the African region – a response to an epidemic that has more than quadrupled the annual number ...More
    August 26, 2005 Posted in News
  • ASHES Elects Board Members
    CHICAGO -- The American Society of Healthcare Environmental Services (ASHES) has elected to its board of directors Brett Higgins, CHESP, manager of environmental services and grounds at Genesis Medical Center in Davenport, Iowa, and Robert McFarland, CHESP, chief of ...More
    August 25, 2005 Posted in News
  • Novavax Reports Positive Preclinical Results on its Novel Vaccine for Pandemic Influenza
    MALVERN, Pa. -- Novavax, Inc., a specialty biopharmaceutical company, today reported preclinical results on the company's novel Virus-Like Particle (VLP) influenza vaccine. Novavax's biological group, led by Dr. Gale Smith, together with Dr. Tumpey and Dr. Bu from the ...More
    August 25, 2005 Posted in News
  • FDA Reminds Consumers That Untreated Juices May Pose Health Risk
    COLLEGE PARK, Md. -- While juices provide many essential nutrients, the U.S. Food and Drug Administration (FDA) is reminding consumers about the dangers of drinking fruit and vegetable juices that have not been treated to kill harmful bacteria. The FDA continues to receive ...More
    August 25, 2005 Posted in News
  • Artesunate Should Become the Treatment of Choice for Severe Malaria
    Artesunate is better than quinine for the treatment of severe malaria in adults, concludes an article in this week’s issue of The Lancet. Quinine is the only drug recommended for the treatment of severe malaria throughout Africa, South America, and most of Asia. But even ...More
    August 25, 2005 Posted in News
  • Sleeping Sickness Epidemic Spreading in Uganda
    Current methods to curb the epidemic of sleeping sickness in eastern Uganda are failing, concludes a Research Letter in this week’s issue of The Lancet. Sleeping sickness is caused by the Trypanosomaparasite, which is carried by the tsetse fly. The epidemic of Trypanosoma ...More
    August 25, 2005 Posted in News
  • MRSA Infection in Vermont Could be Related to Unlicensed Tattoos
    BURLINGTON – Vermont officials from the Secretary of State's Office have initiated an investigation into the source of severe bacterial infections among five young people in Middlebury, Vt., all of whom recently received tattoos. The bacterial infections, known as ...More
    August 23, 2005 Posted in News